Improving the Quality of Life for Patients Through Technologically Enhanced Formulations
Adare Pharma Solutions’ experienced staff of 60 formulation development experts provide our customers with drug formulation solutions for even the most complex dosage form challenges.
We leverage our deep knowledge, innovative technologies, and unparalleled experience to the development of stable, effective drug delivery platforms that allow our customers’ projects to achieve the optimum dosage form needed for faster commercialization.
Capabilities
- Formulation development of
- Solid Dose Tablets
- Capsules
- Liquids
- Solutions
- Pediatric Formulation
- Product Design
- Formulation Optimization
- Sourcing of APIs & Excipients
- Analytical Method Development & Validation
- Prototype Development
- Small-Scale Non-GMP & GMP Development Capabilities
Expertise
- Pre-formulation
- QBD Principles applied with formulation development
- Support including physical characterization
- Pediatric Formulation
- Analytical method development & validation
- IMPD manufacture and QP release
- Technology transfer
- ICH stability programs at all conditions
- Small scale non-GMP and GMP development capability
Speak With An Expert
Srinivasan Shanmugam, Ph.D
Executive Director, Pharmaceutical Sciences, Business Support, and New Technologies
Dr. Srinivasan Shanmugam is involved in the development and expansion of Adare’s pharmaceutical technology portfolio and supports product development, co-development, and tech transfer opportunities. Dr. Shanmugam has a Ph.D. M.S., and a B.S. in Pharmacy. Dr. Shanmugam has more than 20 years of experience in designing and development of conventional, NDDS/alternate, advanced/modified drug delivery systems, and pharmaceutical platform technologies for oral and other routes of administration. His expertise includes enabling technologies for challenging drugs and developing platform technologies. Additionally, his expertise includes patient-centric solutions focusing on pediatric and geriatric populations to achieve dose convenience, flexibility, and precision. Dr. Shanmugam has published numerous research articles, holds multiple patents, and is a reviewer/editorial member of various prestigious journals. Shanmugam’s recent work focuses on product development solutions for special patient populations like pediatric and geriatric populations.
